Giacomo Broglio
Pavia, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Factors associated with comorbidity in hospitalized and non-hospitalized inflammatory bowel disease patients: A single-center, preliminary study.
Journal: Journal of multimorbidity and comorbidity
Published: February 12, 2025
Comparative Safety and Effectiveness of Ustekinumab and Anti-TNF in Elderly Crohn's Disease Patients.
Journal: Inflammatory bowel diseases
Published: January 07, 2024
Recent advances in intestinal fibrosis.
Journal: Molecular aspects of medicine
Published: November 03, 2023
Antenatal thiopurine exposure in women with IBD is associated with intrahepatic cholestasis of pregnancy.
Journal: Expert opinion on drug safety
Published: July 07, 2023
Impact on direct and indirect costs of switching patients with inflammatory bowel disease from intravenous to subcutaneous infliximab (CT-P13).
Journal: BMJ open gastroenterology
Published: January 04, 2023
Role of mucosal immunity and epithelial-vascular barrier in modulating gut homeostasis.
Journal: Internal and emergency medicine
Published: December 11, 2022
Stigmatization and resilience in inflammatory bowel disease patients at one-year follow-up.
Journal: Frontiers in gastroenterology (Lausanne, Switzerland)
Published: October 06, 2022
Diagnostic delay in adult coeliac disease: An Italian multicentre study.
Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
Published: August 24, 2022
Ustekinumab and Vedolizumab Are Equally Safe and Effective in Elderly Crohn's Disease Patients.
Journal: Digestive diseases and sciences
Published: August 05, 2022
Uptake of a Switching Program for Patients Receiving Intravenous Infliximab and Vedolizumab to Subcutaneous Preparations.
Journal: Journal of clinical medicine
Published: August 01, 2022
Showing 1-11 of 11
Last Updated: 09/26/2026